Mammalian alteration/deficiency in activation 3 (Ada3) is essential for embryonic development and cell cycle progression

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29442-29456

  Mohibi, Shakur ^a   Gurumurthy, Channabasavaiah Basavaraju ^a,d   Nag, Alo ^d,e   Wang, Jun ^a   Mirza, Sameer ^a   Mian, Yousaf ^d,f   Quinn, Meghan ^a   Katafiasz, Bryan ^a   Eudy, James ^a   Pandey, Sanjit ^a   Guda, Chittibabu ^a   Naramura, Mayumi ^c,d   Band, Hamid ^a,b,c,d   Band, Vimla ^a,c  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF DELHI   (India)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL TRANSFERASE; CDK INHIBITORS; CELL CYCLE; CELL-CYCLE PROGRESSION; COACTIVATORS; ECTOPIC EXPRESSIONS; EMBRYONIC DEVELOPMENT; ESSENTIAL COMPONENT; GENE TRANSCRIPTIONS; GERMLINE; HISTONE ACETYLATION; INDIRECT EFFECTS; MICROARRAY ANALYSIS; MOUSE EMBRYONIC FIBROBLASTS; S-PHASE;

ACETYLATION; CELL CULTURE; DEFECTS; GENES; MAMMALS; TRANSCRIPTION;

CELLS;

ALTERATION DEFICIENCY IN ACTIVATION 3 PROTEIN; HISTONE ACETYLTRANSFERASE; MEMBRANE PROTEIN; PROTEIN P27; UNCLASSIFIED DRUG;

ADA3 GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; GENETIC TRANSCRIPTION; GENOTYPE; HISTONE ACETYLATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL;

ACETYLATION; ANIMALS; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONES; HUMANS; MICE; MICE, KNOCKOUT; TRANSCRIPTION FACTORS;

ADENOVIRIDAE; MAMMALIA;

EID: 84865529544     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.378901     Document Type: Article

References (47)

1. Schafer, K. A. (1998) The cell cycle: a review. Vet. Pathol 35, 461-478
2. Li, B., Carey, M., and Workman, J. L. (2007) The role of chromatin during transcription. Cell 128, 707-719
3. Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260
4. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705
5. Strahl, B. D., and Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45
6. Roth, S. Y., Denu, J. M., and Allis, C. D. (2001) Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120
7. Carrozza, M. J., Utley, R. T., Workman, J. L., and Côté, J. (2003) The diverse functions of histone acetyltransferase complexes. Trends Genet. 19, 321-329
8. Lee, K. K., and Workman, J. L. (2007) Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 284-295
9. Nagy, Z., and Tora, L. (2007) Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 26, 5341-5357
10. Wang, T., Kobayashi, T., Takimoto, R., Denes, A. E., Snyder, E. L., el-Deiry, W. S., and Brachmann, R. K. (2001) hADA3 is required for p53 activity. EMBO J. 20, 6404-6413
11. Germaniuk-Kurowska, A., Nag, A., Zhao, X., Dimri, M., Band, H., and Band, V. (2007) Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation. Cancer Res. 67, 11789-11797
12. Vernarecci, S., Ornaghi, P., Bâgu, A., Cundari, E., Ballario, P., and Filetici, P. (2008) Gcn5p plays an important role in centromere kinetochore function in budding yeast. Mol. Cell. Biol. 28, 988-996
13. Paolinelli, R., Mendoza-Maldonado, R., Cereseto, A., and Giacca, M. (2009) Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle. Nat. Struct. Mol. Biol. 16, 412-420
14. Orpinell, M., Fournier, M., Riss, A., Nagy, Z., Krebs, A. R., Frontini, M., and Tora, L. (2010) The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates. EMBO J. 29, 2381-2394
15. Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., and Band, V. (2002) Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol. Cell. Biol. 22, 5801-5812
16. Piña, B., Berger, S., Marcus, G. A., Silverman, N., Agapite, J., and Guarente, L. (1993) ADA3: a gene, identified by resistance to GAL4-VP16, with properties similar to and different from those of ADA2. Mol. Cell. Biol. 13, 5981-5989
17. Horiuchi, J., Silverman, N., Marcus, G. A., and Guarente, L. (1995) ADA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in a trimeric complex. Mol. Cell. Biol. 15, 1203-1209
18. Saleh, A., Lang, V., Cook, R., and Brandl, C. J. (1997) Identification of native complexes containing the yeast coactivator/repressor proteins NGG1/ADA3 and ADA2. J. Biol. Chem. 272, 5571-5578
19. Eberharter, A., Sterner, D. E., Schieltz, D., Hassan, A., Yates, J. R., 3rd, Berger, S. L., and Workman, J. L. (1999) The ADA complex is a distinct histone acetyltransferase complex in Saccharomyces cerevisiae. Mol. Cell. Biol. 19, 6621-6631
20. Nag, A., Germaniuk-Kurowska, A., Dimri, M., Sassack, M. A., Gurumurthy, C. B., Gao, Q., Dimri, G., Band, H., and Band, V. (2007) An essential role of human Ada3 in p53 acetylation. J. Biol. Chem. 282, 8812-8820
21. Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G., Wazer, D., Band, H., and Band, V. (2002) Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J. Biol. Chem. 277, 45611-45618
22. Zhao, Y., Lang, G., Ito, S., Bonnet, J., Metzger, E., Sawatsubashi, S., Suzuki, E., Le Guezennec, X., Stunnenberg, H. G., Krasnov, A., Georgieva, S. G., Schüle, R., Takeyama, K., Kato, S., Tora, L., and Devys, D. (2008) A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol Cell 29, 92-101
23. Todaro, G. J., and Green, H. (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313
24. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330
25. Dyson, N. (1998) The regulation of E2F by pRB family proteins. Genes Dev. 12, 2245-2262
26. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573
27. Reynisdóttir, I., Polyak, K., Iavarone, A., and Massagué, J. (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831-1845
28. 1 phase progression. Genes Dev. 13, 1501-1512
29. Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 20, 47-64
30. Carrano, A. C., Eytan, E., Hershko, A., and Pagano, M. (1999) SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199
31. Bretones, G., Acosta, J. C., Caraballo, J. M., Ferrándiz, N., Gómez-Casares, M. T., Albajar, M., Blanco, R., Ruiz, P., Hung, W. C., Albero, M. P., Perez-Roger, I., and León, J. (2011) SKP2 oncogene is a direct MYC target gene, and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J. Biol. Chem. 286, 9815-9825
32. Chen, J., Luo, Q., Yuan, Y., Huang, X., Cai, W., Li, C., Wei, T., Zhang, L., Yang, M., Liu, Q., Ye, G., Dai, X., and Li, B. (2010) Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol. Cell. Biol. 30, 5621-5635
33. Yang, M., Waterman, M. L., and Brachmann, R. K. (2008) hADA2a and hADA3 are required for acetylation, transcriptional activity, and proliferative effects of β-catenin. Cancer Biol. Ther. 7, 120-128
34. Bhaskara, S., Chyla, B. J., Amann, J. M., Knutson, S. K., Cortez, D., Sun, Z. W., and Hiebert, S. W. (2008) Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol. Cell 30, 61-72
35. Burgess, R. J., Zhou, H., Han, J., and Zhang, Z. (2010) A role for Gcn5 in replication-coupled nucleosome assembly. Mol. Cell 37, 469-480
36. Grau, B., Popescu, C., Torroja, L., Ortuño-Sahagún, D., Boros, I., and Ferrús, A. (2008) Transcriptional adaptor ADA3 of Drosophila melanogaster is required for histone modification, position effect variegation, and transcription. Mol. Cell. Biol. 28, 376-385
37. Ciemerych, M. A., and Sicinski, P. (2005) Cell cycle in mouse development. Oncogene 24, 2877-2898
38. Yao, T. P., Oh, S. P., Fuchs, M., Zhou, N. D., Ch'ng, L. E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., and Eckner, R. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372
39. Yamauchi, T., Yamauchi, J., Kuwata, T., Tamura, T., Yamashita, T., Bae, N., Westphal, H., Ozato, K., and Nakatani, Y. (2000) Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc. Natl. Acad. Sci. U.S.A. 97, 11303-11306
40. Kasper, L. H., Fukuyama, T., Biesen, M. A., Boussouar, F., Tong, C., de Pauw, A., Murray, P. J., van Deursen, J. M., and Brindle, P. K. (2006) Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell. Biol. 26, 789-809
41. Guelman, S., Kozuka, K., Mao, Y., Pham, V., Solloway, M. J., Wang, J., Wu, J., Lill, J. R., and Zha, J. (2009) The double-histone-acetyltransferase complex ATAC is essential for mammalian development. Mol. Cell. Biol. 29, 1176-1188
42. Herceg, Z., Hulla, W., Gell, D., Cuenin, C., Lleonart, M., Jackson, S., and Wang, Z. Q. (2001) Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat. Genet. 29, 206-211
43. Liu, X., Tesfai, J., Evrard, Y. A., Dent, S. Y., and Martinez, E. (2003) c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J. Biol. Chem. 278, 20405-20412
44. Liu, X., Vorontchikhina, M., Wang, Y. L., Faiola, F., and Martinez, E. (2008) STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol. Cell. Biol. 28, 108-121
45. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R., and Bradley, A. (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682
46. Martinez, E., Palhan, V. B., Tjernberg, A., Lymar, E. S., Gamper, A. M., Kundu, T. K., Chait, B. T., and Roeder, R. G. (2001) Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol. Cell. Biol. 21, 6782-6795
47. Torok, M. S., and Grant, P. A. (2004) Histone acetyltransferase proteins contribute to transcriptional processes at multiple levels. Adv. Protein Chem. 67, 181-199